Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Ashok K. Chaturvedi"'
Autor:
Olabayo H. Ajetunmobi, Gina Wall, Bruna Vidal Bonifacio, Lucero A. Martinez Delgado, Ashok K. Chaturvedi, Laura K. Najvar, Floyd L. Wormley, Hoja P. Patterson, Nathan P. Wiederhold, Thomas F. Patterson, Jose L. Lopez-Ribot
Publikováno v:
Journal of Fungi, Vol 9, Iss 9, p 879 (2023)
Candidiasis is one of the most frequent nosocomial infections affecting an increasing number of at-risk patients. Candida albicans remains the most frequent causative agent of candidiasis, but, in the last decade, C. auris has emerged as a formidable
Externí odkaz:
https://doaj.org/article/d33924c8872d4402a11a4ecc37d10a10
Autor:
Jesus A. Romo, Christopher G. Pierce, Ashok K. Chaturvedi, Anna L. Lazzell, Stanton F. McHardy, Stephen P. Saville, Jose L. Lopez-Ribot
Publikováno v:
mBio, Vol 8, Iss 6 (2017)
ABSTRACT Candida albicans remains the main etiologic agent of candidiasis, the most common fungal infection and now the third most frequent infection in U.S. hospitals. The scarcity of antifungal agents and their limited efficacy contribute to the un
Externí odkaz:
https://doaj.org/article/69248be2b72a44429a21da8645afd8de
Autor:
Marley C. Caballero Van Dyke, Ashok K. Chaturvedi, Sarah E. Hardison, Chrissy M. Leopold Wager, Natalia Castro-Lopez, Camaron R. Hole, Karen L. Wozniak, Floyd L. Wormley
Publikováno v:
Frontiers in Immunology, Vol 8 (2017)
Cryptococcosis is a fungal disease caused by multiple Cryptococcus serotypes; particularly C. neoformans (serotypes A and D) and C. gattii (serotypes B and C). To date, there is no clinically available vaccine to prevent cryptococcosis. Mice given an
Externí odkaz:
https://doaj.org/article/8a156071758c4a378bfe53d5b02194d2
Autor:
Jesus A. Romo, Christopher G. Pierce, Ashok K. Chaturvedi, Stephen P. Saville, Jose L. Lopez-Ribot
Publikováno v:
Frontiers for Young Minds. 7
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0934ad202be7c6c194ca8ca4e5d91967
https://doi.org/10.3389/frym.2019.00047
https://doi.org/10.3389/frym.2019.00047
Autor:
Floyd L. Wormley, Thomas F. Patterson, Nathan P. Wiederhold, Gina Wall, Ashok K. Chaturvedi, Hoja P Patterson, Jose L. Lopez-Ribot
Publikováno v:
Antimicrobial Agents and Chemotherapy. 62
Since its original isolation in 2009, Candida auris has spread across the globe as a causative agent of invasive candidiasis. C. auris is typically intrinsically resistant to fluconazole and can also be resistant to echinocandins and even amphoterici
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77dbd4665ba2e4eb37e349258de646c1
https://doi.org/10.1128/aac.01084-18
https://doi.org/10.1128/aac.01084-18
Autor:
Ashok K, Chaturvedi, Floyd L, Wormley
Publikováno v:
Methods in molecular biology (Clifton, N.J.). 1625
Cryptococcus neoformans and Cryptococcus gattii, the predominant etiological agents of cryptococcosis, are fungal pathogens that cause disease ranging from a mild pneumonia to life-threatening infections of the central nervous system (CNS). C. neofor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::531d154dca3a5be7e05e0e6c3ce067ea
https://pubmed.ncbi.nlm.nih.gov/28584988
https://pubmed.ncbi.nlm.nih.gov/28584988
Autor:
Ashok K. Chaturvedi, Floyd L. Wormley
Publikováno v:
Methods in Molecular Biology ISBN: 9781493971039
Cryptococcus neoformans and Cryptococcus gattii, the predominant etiological agents of cryptococcosis, are fungal pathogens that cause disease ranging from a mild pneumonia to life-threatening infections of the central nervous system (CNS). C. neofor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d5578dbe36241173df7a2bcf0467d0be
https://doi.org/10.1007/978-1-4939-7104-6_10
https://doi.org/10.1007/978-1-4939-7104-6_10
Publikováno v:
PROTEOMICS. 13:3429-3441
Cryptococcus neoformans , the main causative agent of cryptococcosis, is a fungal pathogen that causes life-threatening meningoencephalitis in immunocompromised patients. To date, there is no vaccine or immunotherapy approved to treat cryptococcosis.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7f2b24a47d0daa67ed347de693af2dd
https://doi.org/10.1002/pmic.201300213
https://doi.org/10.1002/pmic.201300213
Autor:
Floyd L. Wormley, Ashok K. Chaturvedi
Publikováno v:
Expert Review of Vaccines. 12:1261-1272
Cryptococcosis is a fungal disease primarily occurring in immunocompromised individuals, such as AIDS patients, and is associated with high morbidity and mortality. However, cryptococcosis can occur within immunocompetent populations as observed duri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93e47003589bc24bd69ce4cc3f80a334
https://doi.org/10.1586/14760584.2013.840094
https://doi.org/10.1586/14760584.2013.840094
Autor:
Nathan P. Wiederhold, Annette W. Fothergill, Anand Srinivasan, Ashok K. Chaturvedi, Thomas F. Patterson, Jose L. Lopez-Ribot, Floyd L. Wormley, Anand K. Ramasubramanian
Publikováno v:
Virulence. 8(2)
Repositioning old drugs can significantly decrease the time and effort that it takes to develop novel antifungal therapeutics, which represents a pressing and unmet clinical need due to the devastating nature of fungal infections. We have previously
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da5132132528c1e14b7c3fcadd3ba271
https://pubmed.ncbi.nlm.nih.gov/27268469
https://pubmed.ncbi.nlm.nih.gov/27268469